Journal article
Complete pain relief after bevacizumab in a patient with neurofibromatosis type 2.
- Kollár A Department of Medical Oncology, University Hospital of Bern , Switzerland.
- Hewer E
- Kellner-Weldon F
- Ochsenbein A
- 2014-09-17
Published in:
- Acta oncologica (Stockholm, Sweden). - 2015
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Back Pain
Bevacizumab
Female
Humans
Lumbosacral Region
Neoplasms, Multiple Primary
Neurofibromatosis 2
Pain
Young Adult
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.3109/0284186X.2014.956185
- PMID 25225117
- Persistent URL
- https://sonar.ch/global/documents/101941
Statistics
Document views: 36
File downloads: